New hope for bladder cancer patients who Can't have surgery
NCT ID NCT03697850
First seen Nov 18, 2025 · Last updated May 14, 2026 · Updated 23 times
Summary
This study tests whether the drug atezolizumab can help keep bladder cancer from coming back after chemo-radiation therapy. It is for people with muscle-invasive bladder cancer who cannot or choose not to have their bladder removed. The goal is to control the disease and avoid relapse.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Antoine Lacassagne
Nice, France
-
Centre Azureen de Cancerologie
Mougins, 06250, France
-
Centre Georges Francois Leclerc
Dijon, France
-
Centre Jean Perrin
Clermont-Ferrand, France
-
Centre Oscar Lambret
Lille, France
-
Chu Lyon Sud
Pierre-Bénite, France
-
Gustave Roussy
Villejuif, 94800, France
-
Hopital Saint Louis
Paris, France
-
Hôpital Pitie Salpetriere
Paris, France
-
INSTITUT de CANCEROLOGIE DE L'OUEST - site René Gauducheau
Saint-Herblain, France
-
Icm Val D'Aurelle
Montpellier, France
-
Institut Bergonie
Bordeaux, France
Conditions
Explore the condition pages connected to this study.